Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication [NA]

View source ↗

Summary

A clinical trial evaluating three regimens for Helicobacter pylori eradication, including bismuth-amoxicillin-vonoprazan triple therapy, vonoprazan-amoxicillin …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • Bismuth subsalicylate (bismuth subsalicylate)
  • Omeprazole (Omeprazole)
  • Vonoprazan (vonoprazan)
  • clarithromycin (clarithromycin)

Snippet

Sponsor: Kaohsiung Medical University | Conditions: Helicobacter Pylori Eradication | NA | Status: RECRUITING